Skip to content

Clinical trials

Completed Amyloidosis trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Amyloidosis Status: Completed Country / region: Italy Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20071
20083
20102
20111
20133
20142
20151
20163
20172
20194
20202
20212
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fondazione IRCCS Policlinico San Matteo di Pavia5
Ionis Pharmaceuticals, Inc.5
Pfizer4
Alnylam Pharmaceuticals3
Advice Pharma Group srl1
Bellus Health Inc. - a GSK company1
Boston University1
C.T. Development America, Inc.1
Eidos Therapeutics, a BridgeBio company1
European Myeloma Network B.V.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Amyloidosis30
Amyloid Neuropathies, Familial8
Cardiomyopathies5
Alzheimer Disease4
Immunoglobulin Light-chain Amyloidosis4
Amyloidosis, Familial2
Polyneuropathies2
Amyloid Neuropathies1
Anemia, Refractory, with Excess of Blasts1
Arthritis, Rheumatoid1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.